Sersense, Inc.
Publicly observedRochester, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Rochester | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Sersense, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | CANSDRLH1FD7 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant19 Sept 2019Publicly observed
NIH SBIR/STTR award: Automated microfluidic device for blood analysis in neonates
USD 774,788.00 · Eunice Kennedy Shriver National Institute of Child Health and Human Development · Source: NIH RePORTER (opens in a new tab)
- Grant17 Sept 2018Publicly observed
NIH SBIR/STTR award: Detection of extracellular vesicles in urine for diagnosis of preeclampsia
USD 780,138.00 · Eunice Kennedy Shriver National Institute of Child Health and Human Development · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.